Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters. Veröffentlicht vonadmin 27. Juli 2020 Schlick, K, Magnes, T, Ratzinger, L, Jaud, B, Weiss, L, Melchardt, T, Greil, R, Egle, A. https://www.ncbi.nlm.nih.gov/pubmed/30412592